Principal Investigators

    A/Pr Rachel Codd


    University of Sydney

    Contact information of lead PI



    Title of project or programme

    Agents targeting iron in the brain in Parkinson's disease

    Source of funding information

    National Health and Medical Research Council

    Total sum awarded (Euro)

    € 413,080

    Start date of award


    Total duration of award in years



    Research Abstract

    The impaired coordination and tremors experienced by the 64,000 Australians with Parkinson’s disease make managing life at work and home difficult. With 240,000 Australians projected to be living with Parkinson’s disease by 2033, the discovery of agents that slow or stop disease progression is urgent. Iron in the brain has been implicated in Parkinson’s disease. In this project, the performance of new low toxicity agents in altering brain iron distribution will be studied as potential drugs for Parkinson’s disease.

    Further information available at:

Types: Investments < €500k
Member States: Australia
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF